Cronos Group Inc. (CRON) Reports 2020 Fourth Quarter and Full-Year Results

Cronos Group Reports 2020 Fourth Quarter and Full-Year Results   Cronos Group…

The post Cronos Group Inc. (CRON) Reports 2020 Fourth Quarter and Full-Year Results appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Read more
Trulieve Cannabis Corp. (TCNNF) Opens Tamarac’s First Dispensary, Marking 75th Florida Location

Trulieve Opens Tamarac’s First Dispensary, Marking 75th Florida Location Trulieve Cannabis Corp.…

The post Trulieve Cannabis Corp. (TCNNF) Opens Tamarac’s First Dispensary, Marking 75th Florida Location appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Read more
Looking To Invest In Marijuana Stocks? 2 Cannabis Stocks To Watch Next Week
Will Cannabis Business Start Paying The IRS Online?
Best Cannabis Stocks Under $2? Marijuana Penny Stocks Heading Into March
Federal Cannabis Lobbying: Altria Has Entered the Chat

In my experience, lobbying is truly an art and not a science, and a very important art at that. And there’s been no shortage of cannabis lobbying over the years on both the state and federal level. Typically, cannabis trade groups (and there seems to be one for every cannabis topic now, including a recently

The post Federal Cannabis Lobbying: Altria Has Entered the Chat appeared first on Harris Bricken.

Read more
NYU launching $10M Center for Psychedelic Medicine in Manhattan

New York University wants to expand our minds — but in a trippy new way.

Read more
Study: Psychedelics and Music Together Could Treat Addiction

Psychedelic therapy has been gaining not only popularity but acceptance in the medical community in recent years.

Read more
Optimi Health Corp. Completes Oversubscribed $20.7 Million Initial Public Offering, and Announces Listing on the CSE

Optimi Health has commenced public trading (symbol “OPTI”). The Company raised CAD$20.7 million for its IPO financing.

Read more
Field Trip Health Announces Upsize to Previously Announced Bought Deal Public Offering

With its (upsized) $82.875 million dollar financing, Field Trip establishes itself as one of the industry leaders in the psychedelics space.

Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )